Globus Medical Director Sold Shares Worth Over $3.1M
Globus Medical director Tobin James R sold 41,666 shares in two transactions on November 10, 2026, totaling $3,131,547. He no longer owns Class A Common Stock, according to an SEC filing.
How this was made

The 30-second read
Why it matters
The disclosure provides fresh insider activity data, which can influence short‑term trading sentiment.
Market read
Insider sales are closely watched; this $3.1M sale may prompt short‑term price adjustments.
What to watch
No accompanying earnings or guidance change; the sale may not reflect company fundamentals.
Background
Form 4 filing disclosed a director's sale of a sizable stake in Globus Medical.
Ticker impact
Director Tobin James R sold 41,666 shares for $3.13M, ending his ownership of Class A stock.
likely downward pressure as investors price in the insider sell
Form 4 filing is a primary disclosure; a $3M sale by a director is material for a mid‑cap medical device company.
Market effects
May raise concerns for the broader med‑tech sector about insider confidence.
Limited to U.S. investors; no broader regional effect.
Minimal global impact beyond the company's share price.
Counterpoint
The sale could be a routine diversification move, not a negative signal.
Key entities
- CompanyGlobus Medical
Medical device manufacturer listed on NYSE under GMED.
- IndividualTobin James R
Director of Globus Medical who sold shares.



